Elevated serum interleukin‐35 is associated with disease activity in patients with systemic lupus erythematosus

E-ISSN： 1756-185x|20|12|2154-2156

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.20, Iss.12, 2017-12, pp. : 2154-2156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Brief Report: Interleukin‐38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3219-3225

John Wiley & Sons Inc

Access to resources Recommend Favorite

ELEVATED LEVELS OF CHEMOTAXIS INHIBITORY ACTIVITY IN SERA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

THE JOURNAL OF DERMATOLOGY, Vol. 7, Iss. 5, 1980-10 ,pp. : 309-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)‐35 in Murphy Roths Large (MRL)/lpr mice

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 253-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus

By Kan Hong

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 793-800

Informa Healthcare

Access to resources Recommend Favorite

Serum soluble toll‐like receptor 2: a novel biomarker for systemic lupus erythematosus disease activity and lupus‐related cardiovascular dysfunction

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 19, Iss. 7, 2016-07 ,pp. : 685-692

John Wiley & Sons Inc

Access to resources Recommend Favorite